Document is current
Any future updates will be listed below
-
Authors
Dege, Tassilo https://orcid.org/0000-0001-6158-9048
Steffens, Oliver
Kiesel, Özlem
Bychkova, Iana
Leichtfuss, Lara
Schulze-Hagen, Theresa
Goebeler, Matthias
Schmalzing, Marc
Leipe, Jan
Olsavszky, Victor
Strunz, Patrick-Pascal
Glatzel, Caroline
Schmieder, Astrid https://orcid.org/0000-0002-6421-9699
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00037907 at German Clinical Trials RegisterDocuments that mention this clinical trial
Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care
https://doi.org/10.1007/s12325-026-03520-8
-
Funding
Funding for this research was provided by:
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (Z-2/CSP-25)
Else Kröner-Fresenius-Stiftung (TWINSIGHT-09)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 11 December 2025
Accepted: 30 January 2026
First Online: 28 February 2026
Declarations
:
: Tassilo Dege: Travel grants or speaker fees: Leo Pharma, Recordati Rare Diseases, Johnson & Johnson, Sanofi. Matthias Goebeler: Scientific advisory board/ speakers bureau: Almirall, Argenx, Biotest, Fresenius, GSK, Janssen, Leo Pharma, Lilly, Novartis, UCB. Jan Leipe: research support/ clinical trials: Abbott, Boehringer, Pfizer, Gilead, Novartis; Scientific advisory board/ speakers of the bureau: Abbvie, Biogen, BMS, Galapagos, Lilly, medac, MSD, Novartis, Roche, Sanofi, UCB. Victor Olsavszky: Scientific advisory board/ speakers of the bureau: BMS, Johnson & Johnson, and UCB.Patrick-Pascal Strunz: Research support: Novartis, Abbvie, and Chugai. Travel grants or speeker fees: Abbvie, UCB, Janssen, Novartis. Astrid Schmieder: research support/ clinical trials: Abbvie, Boehringer-Ingelheim, Celgene, Eli Lilly, Janssen-Cilag, LEO Pharma, Merck, Novartis, Pfizer; Scientific advisory board/ speakers bureau: Abbvie, Almirall, Hermal, Janssen, LEO, and Novartis, UCB. Oliver Steffens,Özlem Kiesel, Iana Bychkova, Theresa Schulze-Hagen, Marc Schmalzing, Caroline Glatzel and Lara Leichtfuss have nothing to disclose.
: The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the University of Würzburg (reference no. 129/22) and of the Medical Faculty Mannheim, Heidelberg University (reference no. 2022-502). All participants provided written informed consent prior to enrollment. Participants received no compensation for their participation.
